Evidence map›Paper›PMID 23925588›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2014

Difficulties in diagnosing terminal ileitis due to Yersinia pseudotuberculosis.

H F Wunderink, P M Oostvogel, I H M E Frénay, D W Notermans, A Fruth, E J Kuijper

Open access · greenAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Current Challenges inMicroorganisms · 2025
    Review
  2. Review
  3. Extraintestinal Manifestation ofPathogens (Basel, Switzerland) · 2021
    Article
  4. Article
  5. Review
  6. Terminal Ileitis due toBioMed research international · 2020
    Review
  7. Article
  8. Salmonella, Shigella, and yersinia.Clinics in laboratory medicine · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

H F WunderinkDepartment of Medical Microbiology, Leiden University Medical Center, E1-200, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands, h.f.wunderink@lumc.nl.
P M Oostvogel
I H M E Frénay
D W Notermans
A Fruth
E J Kuijper
Leiden University Medical Center · NLAlbert Schweitzer Ziekenhuis · NLMedisch Centrum Haaglanden · NLNational Institute for Public Health and the Environment · NLRobert Koch Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report three patients with terminal ileitis and positive fecal cultures with Yersinia pseudotuberculosis. From one patient, a virulence plasmid (pYV)-negative Y. pseudotuberculosis was isolated, which represents the second finding of a pYV-negative isolate associated with human disease. All patients were treated with ciprofloxacin and fully recovered. Since conventional culture methods for yersiniosis are gradually replaced with molecular tests not recognizing Y. pseudotuberculosis, we recommend to include a specific culture medium or to apply a specific polymerase chain reaction (PCR) assay on fecal samples from patients suspected of terminal ileitis.

Indexed as

AdolescentAdultAnti-Bacterial AgentsBacteriological TechniquesCiprofloxacinCrohn DiseaseCulture MediaFemaleHumansPlasmidsPolymerase Chain ReactionTreatment OutcomeYersinia pseudotuberculosisYersinia pseudotuberculosis InfectionsYoung AdultAnti-Bacterial AgentsCiprofloxacinCulture Media

Identifiers

PMID23925588
OpenAlexW2020567234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.